Pages that link to "Q35801915"
Jump to navigation
Jump to search
The following pages link to A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis (Q35801915):
Displaying 50 items.
- The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis (Q26740410) (← links)
- Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice (Q27301043) (← links)
- Increased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis Antigen (Q27302995) (← links)
- Mycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human Tuberculosis (Q28083909) (← links)
- Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis (Q28730427) (← links)
- DNA vaccines and their application against parasites--promise, limitations and potential solutions. (Q33208276) (← links)
- Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. (Q33788201) (← links)
- Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens (Q33843258) (← links)
- The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis. (Q33883504) (← links)
- DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice. (Q34975023) (← links)
- Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis (Q34975770) (← links)
- Efficacy of a vaccine formula against tuberculosis in cattle (Q35034673) (← links)
- Cattle as a model for development of vaccines against human tuberculosis (Q36027515) (← links)
- Identification of immune response correlates for protection against bovine tuberculosis (Q36248313) (← links)
- Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis (Q36252595) (← links)
- Recent developments in veterinary vaccinology (Q36305113) (← links)
- The pathogenesis and pathology of bovine tuberculosis with insights from studies of tuberculosis in humans and laboratory animal models (Q36323872) (← links)
- DNA vaccines for therapy of tuberculosis: where are we now? (Q36326443) (← links)
- Progress in the development of tuberculosis vaccines for cattle and wildlife. (Q36330400) (← links)
- Vaccines for bovine tuberculosis: current views and future prospects. (Q36350586) (← links)
- Fungal heat-shock proteins in human disease (Q36378357) (← links)
- Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. (Q36402053) (← links)
- Development of cattle TB vaccines in the UK. (Q36471916) (← links)
- Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A (Q36540068) (← links)
- Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone (Q36672533) (← links)
- Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens. (Q36682418) (← links)
- Should a new tuberculosis vaccine be administered intranasally? (Q36744991) (← links)
- The immunology of bovine tuberculosis and progression toward improved disease control strategies (Q36760785) (← links)
- DNA vaccines against mycobacterial diseases (Q36895737) (← links)
- Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida (Q37162315) (← links)
- Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis (Q37274874) (← links)
- Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection (Q37309281) (← links)
- RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection. (Q37582824) (← links)
- Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis (Q37582879) (← links)
- A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice (Q37623702) (← links)
- A Mycobacterium bovis BCG-naked DNA prime-boost vaccination strategy induced CD4⁺ and CD8⁺ T-cell response against Mycobacterium tuberculosis immunogens (Q37704762) (← links)
- Update on vaccination of cattle and wildlife populations against tuberculosis. (Q37855175) (← links)
- DIVA reagents for bovine tuberculosis vaccines in cattle (Q37909428) (← links)
- Bovine tuberculosis vaccine research: historical perspectives and recent advances. (Q37985287) (← links)
- Progress in the development of DNA vaccines against foot-and-mouth disease (Q38006997) (← links)
- Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans (Q38156497) (← links)
- Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection. (Q38435794) (← links)
- Relevance of bovine tuberculosis research to the understanding of human disease: historical perspectives, approaches, and immunologic mechanisms (Q38696320) (← links)
- Development of immune-diagnostic reagents to diagnose bovine tuberculosis in cattle (Q38746999) (← links)
- Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle (Q40304602) (← links)
- Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis (Q40396473) (← links)
- Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis (Q40763818) (← links)
- Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity? (Q41854304) (← links)
- Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG (Q41908519) (← links)
- Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected cattle (Q44322701) (← links)